MARKETWIRE.NET

Decode Your Next Market Move

Global Industry Analysts, Inc. (GIA) launches comprehensive analysis of industry segments, market trends, growth drivers, market share, size and demand forecasts on the global Efficacy Testing market. Market segmentation includes segment (Consumables, Instruments, and Services).

Find Out More About Regions, Brands, Dominant, Active & Niche Companies Covered in the Report

24 November 4:22 a.m., Silicon Valley, California - According to the new market research report, the global market for Efficacy Testing is projected to grow at a CAGR of 10.7% reach US$866.3 million by 2027, driven by stringent regulations for drug development, and increasing government funding for research activities in the area of life sciences. The global efficacy testing market is driven by increasing support from governments across the world for pharmaceutical and biotechnology industries. This trend is in turn resulting in increased investments for research and development activities in these sectors and contributing to market growth. Moreover, the growing application of antimicrobial efficacy testing for different types of medical devices, in cosmetic and pharmaceutical industries, and R&D investments in the life sciences space are anticipated to boost the market. Increasing pharmaceutical outsourcing activities in emerging markets would also offer growth opportunities for leading players in the efficacy testing market.

The global efficacy testing market is driven by regulations for the safety and efficacy of pharmaceutical products. Among the various concerns, the effectiveness of the active pharmaceutical ingredient (API) is the major concern for the validation of pharmaceutical products. Over the past decades, a number of techniques were developed for preservative efficacy testing (PET) by regulatory agencies, industry organizations and standards organizations, as well as individual agencies such as the International Conference on Harmonisation (ICH) for Technical Requirements for Registration of Pharmaceuticals for Human Use and good clinical practice (GCP). These regulatory bodies mainly aim at establishing scientific soundness and good documentation standard. Among the different types of approaches and protocols that were proposed and developed, the most widely accepted and commonly used evaluation criteria is the microbial challenge test.

In both the US and Europe, the utilization of disinfectants in the form of agents for controlling the environment's microbiological contamination is not only well established, but is also governed by regulatory agencies. In the US, chemical disinfectants are registered and controlled by the country's Environmental Protection Agency (EPA) through the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). Likewise, in Europe, the marketing and utilization of biocidal products is regulated by the Biocidal Products Regulation (BPR) 528/2012. Under FIFRA, chemical disinfectants are classified as antimicrobial pesticides. Under both FIFRA and BPR, disinfectant manufacturers need to provide data demonstrating the disinfectants' efficacy claims, namely whether the disinfectants are viricidal, sporicidal, fungicidal, or bactericidal, prior to their registration.

Research Methodology
This latest edition of the research study is conducted and published by Global Industry Analysts, Inc., in close collaboration with senior executives in the industry driving strategy, business development, marketing, sales, product management, technology and operations. The views, opinions and findings presented are based on validated engagements from a total executive pool size of 2267. Among this pool, 408 direct interactions with domain experts were carried out via our proprietary market research platform, MarketGlass. Among the 68 unique participations, a total of 31 validated responses were received as part of this report's primary research outreach program. We are unique in the industry to provide our clients with the validated list executive engagements and the complete project data stack.

Key Competitors Covered in the Report -
Merck KGaA
bioMerieux SA
Charles River Laboratories International, Inc.
SGS SA
American Type Culture Collection (ATCC)
WuXi AppTec
North American Science Associates, Inc.
Pacific Biolabs
Toxikon Corporation

Segments Covered in the Report -
Segment (Consumables, Instruments, Services)
Type (Disinfectant Efficacy Testing, Antimicrobial Efficacy Testing)
Application (Pharmaceutical Manufacturing, Cosmetics & Personal Care Products, Medical Devices)

Geographies Analyzed in the Report -
World
USA
Canada
Japan
China
Europe
France
Germany
Italy
UK
Spain
Russia
Rest of Europe
Asia-Pacific
Australia
India
South Korea
Rest of Asia-Pacific
Latin America
Argentina
Brazil
Mexico
Rest of Latin America
Middle East
Iran
Israel
Saudi Arabia
UAE
Rest of Middle East
Africa.

View Executive Engagement Dashboards, COVID Impact Questionnaires & Get Complimentary Access to Methodology & Full-Text Secondary Sources

For enquiries e-mail us at sales@strategyR.com .

For cutting edge analyst reviews on top industries, follow us on Twitter and connect with us on LinkedIn

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) (www.strategyr.com) is the world`s only influencer driven AI powered market research company. Serving more than 41,000 clients from 36 countries, GIA is recognized for accurate forecasting of markets and industries for 33 years, offering the widest coverage of topics, geographic markets, competitive brands, and companies profiled.

Contact Us:
Zak Ali
Director, Corporate Communications
Global Industry Analysts, Inc.
Phone: 1-408-528-9966
Email: sales@StrategyR.com